Clinical Trial Update: REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men [NA]

View source ↗

Summary

A clinical trial comparing the Rezūm System to dual drug therapy for symptomatic benign prostatic hyperplasia is currently active but not recruiting. The sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Dual Drug Therapy (alpha-blocker + 5-alpha-reductase inhibitor)
• Rezūm System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Benign Prostatic Hyperplasia (BPH) | NA | Status: ACTIVE_NOT_RECRUITING